GENEART wins STEP-Award for Growing Business
At a festive event in Frankfurt, GENEART AG was honoured with the "STEP-Award" and in addition to this received the prize in the category "Processes". The special feature of the "STEP-Awards": Distinction is awarded to companies who have succeeded in the transition from the research phase with a successful product to making this ready for the market, and are now in the initial rapid growth phase. GENEART AG was able to further develop the process of manufacturing synthetic genes, as a precursor for the development of modern medicines and vaccines, from individual preparation to industrial conveyor belt production. Since its foundation in 1999, its production has at least doubled every year. Further prize winners were Morphosys AG, ProBioGen AG and Infectopharm GmbH. Main promoters of the "STEP-Awards" are the Commerzbank, Mainova and Siemens. Around 100 technology companies in the areas of pharmaceuticals, chemistry, life sciences, bio-/nanotechnology and materials management from Germany, Austria and Switzerland took part in the competition. The concept behind the "STEP-Award" was a competition for enterprises for the promotion of growing businesses that were on the threshold of a "big breakthrough". The company received 55,000 € in cash in prize money and can enjoy a comprehensive service packet from promoters and sponsors of the "STEP-Award". The services range from patent research to consultancy services, and to participation in seminars on law and communication.
For more information see: